文献速递慢阻肺

运动时双水平无创通气减少重度至极重度COPD患者动态肺过度充气并改善骑行耐力时间

Bilevel Noninvasive Ventilation During Exercise Reduces Dynamic Hyperinflation and Improves Cycle Endurance Time in Severe to Very Severe COPD.
PubMed 文献 · Chest · 2021-07-02

该随机交叉试验纳入19例重度至极重度COPD患者(FEV1 1.02±0.24 L,占预计值39%±6%),比较运动时无无创通气、标准呼气末正压(S-EPAP 5 cm H2O)无创通气及个体化滴定EPAP(T-EPAP)无创通气三种条件。结果显示两种无创通气均较无无创通气显著提高等时点吸气容量和骑行耐力时间,而S-EPAP与T-EPAP间无差异。

要点

  • 运动时双水平无创通气可减少COPD患者动态肺过度充气并延长骑行耐力时间。
  • 标准EPAP 5 cm H2O已足以获得上述获益,无需个体化滴定EPAP。
  • 适用人群为静息肺过度充气且运动中出现动态肺过度充气的重度COPD患者。

核心结论

  • 在运动中出现动态肺过度充气的COPD患者中,运动时无创通气可减少动态肺过度充气并增加骑行耐力时间。
  • 标准EPAP 5 cm H2O足以获得这些获益,与个体化滴定EPAP相比无差异。

研究设计与样本

  • 随机交叉试验,研究者和参与者对无创通气干预设盲。
  • 共19例参与者,FEV1为1.02±0.24 L(占预计值39%±6%)。
  • 每例完成三次恒定功率耐力骑行测试,随机顺序为无无创通气、S-EPAP无创通气、T-EPAP无创通气。
  • 主要结局为等时点吸气容量和运动耐力时间,采用线性混合模型分析。

主要发现

  • 与无无创通气相比,S-EPAP无创通气的等时点吸气容量平均差异为0.19 L(95%CI 0.10-0.28),耐力时间平均差异为153 s(95%CI 24-280)。
  • 与无无创通气相比,T-EPAP无创通气的等时点吸气容量平均差异为0.22 L(95%CI 0.13-0.32),耐力时间平均差异为145 s(95%CI 28-259)。
  • S-EPAP无创通气与T-EPAP无创通气之间无差异。

临床怎么用

  • 对静息肺过度充气且运动中出现动态肺过度充气的重度至极重度COPD患者,可考虑运动时使用双水平无创通气以改善动态肺过度充气和运动耐力。
  • 呼气末正压可选用标准5 cm H2O,无需常规个体化滴定EPAP。

局限性

  • 样本量较小(N=19)。
  • 研究为单次运动测试的交叉设计,未评估长期临床结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: During exercise, dynamic hyperinflation (DH), measured by a reduction in inspiratory capacity (IC), increases exertional dyspnea and reduces functional capacity in many patients with severe COPD. Although noninvasive ventilation (NIV) during exercise can improve exercise duration, the effect on DH is unclear. RESEARCH QUESTIONS: In people with COPD, resting hyperinflation, and evidence of DH during exercise, does bilevel NIV during exercise reduce DH and increase endurance time compared with exercise with no NIV, and does NIV with an individually titrated expiratory positive airway pressure (T-EPAP) reduce DH and increase exercise endurance time more than NIV with standardized EPAP (S-EPAP) of 5 cm H2O? STUDY DESIGN AND METHODS: A randomized crossover trial in which investigators and participants were blinded between NIV interventions was performed. Participants (N = 19; FEV1 of 1.02 ± 0.24 L (39% ± 6% predicted) completed three constant work rate endurance cycle tests in random order-no NIV, NIV with S-EPAP, and NIV with T-EPAP-during exercise. Primary outcomes were isotime IC and exercise endurance time. Outcome measures from each intervention were compared at isotime and at end exercise by using a linear mixed-model analysis. RESULTS: Compared with no NIV, isotime IC and endurance time were greater with both NIV with S-EPAP (mean difference: 95% CI, 0.19 L [0.10-0.28]; 95% CI, 153 s [24-280], respectively) and T-EPAP (95% CI, 0.22 L [0.13-0.32]; 95% CI, 145 s [28-259], respectively). There was no difference between NIV with S-EPAP and NIV with T-EPAP. INTERPRETATION: In people with COPD and DH during exercise, NIV during exercise reduced DH and increased cycle endurance time. An S-EPAP of 5 cm H2O was adequate to obtain these benefits. TRIAL REGISTRY: Australian New Zealand Clinical Trials Registry; No.: ACTRN12613000804785; URL: http://www.anzctr.org.au.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Dennis CJ, Menadue C, Schneeberger T, et al. Bilevel Noninvasive Ventilation During Exercise Reduces Dynamic Hyperinflation and Improves Cycle Endurance Time in Severe to Very Severe COPD. Chest. 2021. PMID: 34224690. doi:10.1016/j.chest.2021.06.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。